Generation and characterization of human monoclonal antibodies to G5, a linear neutralization epitope on glycoprotein of rabies virus, by phage display technology

Microbiology and Immunology

Volumn 52, Issue 2, 2008, Pages 89-93

  Zhao, Xiao Ling ^a   Yin, Jun ^b   Chen, Wei Qiang ^a   Jiang, Ming ^b   Yang, Guan ^b   Yang, Zhi Hua ^a  

^a INSTITUTE OF HEALTH AND ENVIRONMENTAL MEDICINE   (China)

^b BEIJING INSTITUTE OF MICROBIOLOGY AND EPIDEMIOLOGY   (China)

Author keywords

G5; Phage display; Rabies virus; Single chain fragments

Indexed keywords

EPITOPE; GLYCOPROTEIN; HUMAN MONOCLONAL ANTIBODY; SINGLE CHAIN FRAGMENT VARIABLE ANTIBODY; SYNTHETIC PEPTIDE; VIRUS GLYCOPROTEIN; GLYCOPROTEIN G, RABIES VIRUS; IMMUNOGLOBULIN FRAGMENT; MONOCLONAL ANTIBODY; PEPTIDE LIBRARY; VIRUS ANTIBODY; VIRUS ANTIGEN; VIRUS ENVELOPE PROTEIN;

ANTIBODY AFFINITY; ANTIBODY PRODUCTION; ANTIGEN BINDING; ANTIGEN RECOGNITION; ANTIGEN SPECIFICITY; ARTICLE; CLONE; CONTROLLED STUDY; MOLECULAR CLONING; MOLECULAR RECOGNITION; NONHUMAN; PHAGE DISPLAY; PROTEIN PURIFICATION; RABIES VIRUS; VIRUS GENE; VIRUS NEUTRALIZATION; VIRUS STRAIN; AMINO ACID SEQUENCE; GENETICS; HUMAN; IMMUNOLOGY; ISOLATION AND PURIFICATION; MOLECULAR GENETICS; SERODIAGNOSIS; VIRUS CULTURE;

RABIES VIRUS;

AMINO ACID SEQUENCE; ANTIBODIES, MONOCLONAL; ANTIBODIES, VIRAL; ANTIGENS, VIRAL; EPITOPES; GLYCOPROTEINS; HUMANS; IMMUNOGLOBULIN FRAGMENTS; MOLECULAR SEQUENCE DATA; NEUTRALIZATION TESTS; PEPTIDE LIBRARY; PLAQUE ASSAY; RABIES VIRUS; VIRAL ENVELOPE PROTEINS;

EID: 51449102409     PISSN: 03855600     EISSN: 13480421     Source Type: Journal    
DOI: 10.1111/j.1348-0421.2008.00016.x     Document Type: Article

References (21)

1. Sun B., Auslander M., Conti L. et al. (2007) Compendium of animal rabies prevention and control. J Am Vet Med Assoc 230: 833-4.
2. Warrell D.A., Warrell M.J. (1995) Human rabies: a continuing challenge in the tropical world. Schweiz Med Wochenschr 125: 879-85.
3. Dietzschold B.M., Gore P., Casali Y. et al. (1990) Biological characterization of human monoclonal antibodies to rabies virus. J Virol 64: 3087-90.
4. Hanlon C.A., DeMattos C.A., DeMattos C.C. et al. (2001) Experimental utility of rabies virus-neutralizing human monoclonal antibodies in post-exposure prophylaxis. Vaccine 19: 3834-42.
5. Montano-Hirose J.A., Lafage M., Weber P. et al. (1993). Protective activity of a murine monoclonal antibody against European bat lyssavirus 1 (EBL1) infection in mice. Vaccine 11: 1259-66.
6. World Health Organization. (2002) Monoclonal antibody combination for rabies post exposure treatment: report of a WHO consultation, 23-24 May 2002.World Health Organization document R2-370-15.World Health Organization, Geneva, Switzerland.
7. Zhao X.L., Yin J., Wang H. et al. (2004) Construction of human phage-displayed scFv library and selection of the scFv against rabies virus. Chin J Cell Mol Immunol 20(2): 243-7.
8. Dietzschold M., Gore M., Marchadier D. et al. (1990) Structural and immunological characterization of a linear virus neutralizing epitope of the rabies virus glycoprotein and its possible use in a synthetic vaccine. J Virol 64: 3804-9.
9. Roger W.J., Vander H. et al. (1993) Structure and functional studies on a unique linear neutralizing antigen site (G5) of rabies virus glycoprotein. J Gen Virol 74: 1593-8.
10. James D.M., Hennie R.H., Timithy P.B. et al. 1991. By-passing immunization human antibodies from V-gene libraries displayed on phage. J Mol Biol 222: 581-97.
11. Macdonald R.A., Hosking C.S., Jones C.L. (1988) The measurement of relative affinity by ELISA using thiocyanate elution. J Immunol Methods 106: 91-4.
12. Jeremy M., Kathryn C., Henry H. et al. (2005) Mumps virus-specific antibody titers from pre-vaccine era sera: comparison of the plaque reduction neutralization assay and enzyme immunoassays. J Clin Microbiol 43: 4847-51.
13. Yokota T., Milenic D.E., Whitlow M. et al. (1992) Rapid tumor penetration of a single-chain Fv and comparison with other immunoglobulin forms. Cancer Res 52: 3402-8.
14. Irie T., Kawai A. (2005) Further studies on the mechanism of rabies virus neutralization by a viral glycoprotein-specific monoclonal antibody. Microbiol Immunol 49: 721-31.
15. Dietzschold, B. (1993) Antibody-mediated clearance of viruses from the mammalian central nervous system. Trends Microbiol 1: 63-6.
16. Bakker A.B.H., Marissen W.E., Kramer R.A. et al. (2005) Novel human monoclonal antibody combination effectively neutralizing natural rabies virus variants and individual in vitro escape mutants. J Virol 79(14): 9062-8.
17. Coulon P.J., Ternaux P., Flamand A. et al. (1998) An avirulent mutant of rabies virus is unable to infect motoneurons in vivo and in vitro. J Virol 72: 273-8.
18. Diallo, A. (1986) Avirulent mutants of the rabies virus: change in site III of the glycoprotein. Ann Rech Vet 17(1): 3-6.
19. Seif I.P., Coulon P.E., Rollin et al. (1985) Rabies virulence: effect on pathogenicity and sequence characterization of rabies virus mutations affecting antigenic site III of the glycoprotein. J Virol 53: 926-34.
20. Tuffereau C., Benejean J., Blondel D. et al. (1998) Low-affinity nerve-growth factor receptor (P75NTR) can serve as a receptor for rabies virus. EMBO J 17: 7250-9.
21. Lafon M.T., Wiktor J., Macfarlan R.I. (1983) Antigenic sites on the CVS rabies virus glycoprotein: analysis with monoclonal antibodies. J Gen Virol 64: 843-51.